conference reporter

First-in-Class Prospects and New Targets in Advanced Prostate Cancer

by Christopher J. Logothetis, MD

Research focusing on new targeting strategies for metastatic castration-resistant prostate cancer (mCRPC) is burgeoning, as reflected by the procee......READ MORE

LATEST IN EXPERT PERSPECTIVES

Browse More Articles